Menlo Park, California
United States
8
2023-12-07
8
2024-03-05
These are the the leading inventors for applications assigned to COMBANGIO, INC.:
COMBANGIO, INC. based in Menlo Park, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Methods for treating an ocular condition with cellular fibronectin compositions
#2 | 2023-01-05 ✅ Patent 11,891,428 granted on 2024-02-06Cellular fibronectin compositions
#3 | 2023-01-05 ✅ Patent 12,187,784 granted on 2025-01-07Processes for making a cellular fibronectin composition
#4 | 2021-12-02 ✅ Patent 12,186,430 granted on 2025-01-07Lyophilized mesenchymal stem cell derived secretome and uses thereof
#5 | 2021-06-24 ✅ Patent 11,129,853 granted on 2021-09-28Processes for making and using a mesenchymal stem cell derived secretome
#6 | 2021-02-25 ✅ Patent 11,654,160 granted on 2023-05-23Processes for making and using a mesenchymal stem cell derived secretome
#7 | 2020-10-15 ✅ Patent 10,881,693 granted on 2021-01-05Processes for making and using a mesenchymal stem cell derived secretome
#8 | 2020-09-01 ✅ Patent 10,758,571 granted on 2020-09-01Processes for making and using a mesenchymal stem cell derived secretome
Also check out Combangio, Inc.'s (Menlo Park, United States) applicant profile with 12 patent applications submitted.
352823 ⎘